New Key Statistics Module, Z-Score and F-Score
NAS:TCRX Key Ratios
| Market Cap $ M | 156.52 |
| Enterprise Value $ M | -24.24 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.65 |
| Price/Sales | 28.85 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 9.00 |
| EPS (TTM) $ | -0.96 |
| Beneish M-Score | -3.2 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.23 |
| EV-to-EBITDA | 0.24 |
| PEG | -- |
| Shares Outstanding M | 56.51 |
| Net Margin (%) | -1,188.88 |
| Operating Margin % | -1,276.07 |
| Pre-tax Margin (%) | -1,188.88 |
| Quick Ratio | 9.56 |
| Current Ratio | 9.56 |
| ROA % (ttm) | -36.44 |
| ROE % (ttm) | -60.03 |
| ROIC % (ttm) | -107.12 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.72 |
TCRX Number of Guru Trades
TCRX Volume of Guru Trades
Gurus Latest Trades with NAS:TCRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TCRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TScan Therapeutics Inc Insider Transactions
No Available Data
News about NAS:TCRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers